Literature DB >> 24810632

Intracerebral hemorrhage in mouse models: therapeutic interventions and functional recovery.

Balachandar Kathirvelu1, S Thomas Carmichael.   

Abstract

There has been strong pre-clinical research on mechanisms of initial cell death and tissue injury in intracerebral hemorrhage (ICH). This data has led to the evaluation of several therapeutics for neuroprotection or the mitigation of early tissue damage. Most of these studies have been done in the rat. Also, there has been little study of the mechanisms of tissue repair and recovery. This review examines the testing of candidate therapeutics in mouse models of ICH for their effect on tissue protection and repair. This review will help the readers compare it to the extensively researched rat model of ICH and thus enhance work that are pending in mouse model.

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24810632      PMCID： PMC4226812          DOI： 10.1007/s11011-014-9559-7

Source DB:  PubMed          Journal:  Metab Brain Dis        ISSN： 0885-7490            Impact factor:   3.584


  98 in total

Review 1.  Neuroprotective gases--fantasy or reality for clinical use?

Authors:  Jiao Deng; Chong Lei; Yu Chen; Zongping Fang; Qianzi Yang; Haopeng Zhang; Min Cai; Likai Shi; Hailong Dong; Lize Xiong
Journal:  Prog Neurobiol       Date:  2014-01-15       Impact factor: 11.685

2.  Matrix metalloproteinase (MMP)-12 expression has a negative impact on sensorimotor function following intracerebral haemorrhage in mice.

Authors:  Jennifer E A Wells; Jeff Biernaskie; Aleksandra Szymanska; Peter H Larsen; V Wee Yong; Dale Corbett
Journal:  Eur J Neurosci       Date:  2005-01       Impact factor: 3.386

Review 3.  Intracerebral hemorrhage.

Authors:  Neeraj Badjatia; Jonathan Rosand
Journal:  Neurologist       Date:  2005-11       Impact factor: 1.398

4.  Natural and synthetic retinoids afford therapeutic effects on intracerebral hemorrhage in mice.

Authors:  Hideaki Matsushita; Masanori Hijioka; Akinori Hisatsune; Yoichiro Isohama; Koichi Shudo; Hiroshi Katsuki
Journal:  Eur J Pharmacol       Date:  2012-03-23       Impact factor: 4.432

5.  Toll-like receptor 4 contributes to poor outcome after intracerebral hemorrhage.

Authors:  Lauren H Sansing; Tajie H Harris; Frank A Welsh; Scott E Kasner; Christopher A Hunter; Katalin Kariko
Journal:  Ann Neurol       Date:  2011-10       Impact factor: 10.422

Review 6.  Therapeutic hypothermia and controlled normothermia in the intensive care unit: practical considerations, side effects, and cooling methods.

Authors:  Kees H Polderman; Ingeborg Herold
Journal:  Crit Care Med       Date:  2009-03       Impact factor: 7.598

7.  Hematoma resolution as a target for intracerebral hemorrhage treatment: role for peroxisome proliferator-activated receptor gamma in microglia/macrophages.

Authors:  Xiurong Zhao; Guanghua Sun; Jie Zhang; Roger Strong; Weitao Song; Nicole Gonzales; James C Grotta; Jaroslaw Aronowski
Journal:  Ann Neurol       Date:  2007-04       Impact factor: 10.422

8.  Prevalence of hypertension and controlled hypertension - United States, 2007-2010.

Authors:  Cathleen D Gillespie; Kimberly A Hurvitz
Journal:  MMWR Suppl       Date:  2013-11-22

9.  Translating basic science research to clinical application: models and strategies for intracerebral hemorrhage.

Authors:  Christopher C Leonardo; Sean Robbins; Sylvain Doré
Journal:  Front Neurol       Date:  2012-05-29       Impact factor: 4.003

10.  Tumor necrosis factor α antagonism improves neurological recovery in murine intracerebral hemorrhage.

Authors:  Beilei Lei; Hana N Dawson; Briana Roulhac-Wilson; Haichen Wang; Daniel T Laskowitz; Michael L James
Journal:  J Neuroinflammation       Date:  2013-08-20       Impact factor: 8.322
View more
  8 in total

1.  Optimized tPA: A non-neurotoxic fibrinolytic agent for the drainage of intracerebral hemorrhages.

Authors:  Romain Goulay; Mikaël Naveau; Thomas Gaberel; Denis Vivien; Jérôme Parcq
Journal:  J Cereb Blood Flow Metab       Date:  2017-07-25       Impact factor: 6.200

Review 2.  Basic and Translational Research in Intracerebral Hemorrhage: Limitations, Priorities, and Recommendations.

Authors: 
Journal:  Stroke       Date:  2018-04-04       Impact factor: 7.914

3.  Authors' reply to Whitlock: Perispinal etanercept for post-stroke neurological and cognitive dysfunction: scientific rationale and current evidence.

Authors:  Tracey A Ignatowski; Robert N Spengler; Edward Tobinick
Journal:  CNS Drugs       Date:  2014-12       Impact factor: 5.749

4.  Biomarker and Drug Target Discovery Using Quantitative Proteomics Post-Intracerebral Hemorrhage Stroke in the Rat Brain.

Authors:  Shuixiang Deng; Shengjie Feng; Wei Wang; Feng Zhao; Ye Gong
Journal:  J Mol Neurosci       Date:  2018-11-14       Impact factor: 3.444

5.  Acute Treatment With Fingolimod Does Not Confer Long-Term Benefit in a Mouse Model of Intracerebral Haemorrhage.

Authors:  Andrea C Diaz Diaz; Jennifer A Shearer; Kyle Malone; Christian Waeber
Journal:  Front Pharmacol       Date:  2021-01-08       Impact factor: 5.810

6.  Ergosta-7,9(11),22-trien-3β-ol Alleviates Intracerebral Hemorrhage-Induced Brain Injury and BV-2 Microglial Activation.

Authors:  Po-Jen Hsueh; Mong-Heng Wang; Che-Jen Hsiao; Chih-Kuang Chen; Fan-Li Lin; Shu-Hsien Huang; Jing-Lun Yen; Ping-Huei Tsai; Yueh-Hsiung Kuo; George Hsiao
Journal:  Molecules       Date:  2021-05-17       Impact factor: 4.411

7.  Uncovering the Rosetta Stone: Report from the First Annual Conference on Key Elements in Translating Stroke Therapeutics from Pre-Clinical to Clinical.

Authors:  Gregory J Bix; Justin F Fraser; William J Mack; S Thomas Carmichael; Miguel Perez-Pinzon; Halina Offner; Lauren Sansing; Francesca Bosetti; Cenk Ayata; Keith R Pennypacker
Journal:  Transl Stroke Res       Date:  2018-04-10       Impact factor: 6.829

8.  Matrix Metalloproteases-Mediated Cleavage on β-Dystroglycan May Play a Key Role in the Blood-Brain Barrier After Intracerebral Hemorrhage in Rats.

Authors:  Xin Zhang; Yunhe Gu; Peitong Li; Anqi Jiang; Xiaomeng Sheng; Xin Jin; Yue Shi; Guozhong Li
Journal:  Med Sci Monit       Date:  2019-01-28
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.